Clinical trial
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
NCT00092937 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00092937 |
|---|---|
| Title | Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant |
| Official title | Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient With Partial Reconstitution Post Initial Allogeneic Transplantation |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Granulomatous Disease, Chronic |
| Intervention type | Drug |
| Interventions | Busulfan |
| Enrollment | 2 |
| Start date | Sep 23, 2004 |
| Primary completion | Apr 6, 2010 |
| Completion | Apr 6, 2010 |
| First posted | Sep 27, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: